Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 35576009.
- Also identified by DOI 10.1001/jamanetworkopen.2022.11897 and PMC identifier 9112067.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study compares the antispike antibody titers of the mRNA-1273 and BNT162b2 vaccines for SARS-CoV-2 in incrementally immunosuppressed patients.
Medical subject headings
- COVID-19
- Vaccines